Literature DB >> 31096225

Radiosurgery for Behavioral Disorders.

Roberto Martínez-Álvarez1.   

Abstract

Psychiatric illnesses create great suffering for patients and the medical solution is sometimes limited. The experience observed after treating patients with obsessive-compulsive disorder (OCD), depression, and anorexia nervosa by Gamma Knife radiosurgery (GKRS) is presented. Ten patients with medically refractory OCD, 3 patients with depression resistant to medical treatment and electroconvulsive therapy, and 5 patients with refractory anorexia nervosa have been treated. Bilateral anterior capsulotomy has been performed to treat OCD and bilateral cingulotomy has been applied to treat severe depression and anorexia nervosa. The accumulated experience about treatment of OCD by GKRS is reviewed. In our experience, 70% of OCD patients achieved a full response. We observed a significant improvement in patients with depression and anorexia nervosa evidenced by the scales of assessment (mean reduction of 40% in the Beck Depression Inventory at 1-year follow-up and 40% average increase of body mass index at 6-month follow-up). No side effects have been observed. These procedures are effective in reducing obsession, compulsion, depression, and anxiety, improving the quality of life of the patients without side effects.
© 2019 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2019        PMID: 31096225     DOI: 10.1159/000493076

Source DB:  PubMed          Journal:  Prog Neurol Surg        ISSN: 0079-6492


  2 in total

1.  Gamma Capsulotomy: A Valid Option for Refractory Obsessive Compulsive Disorder.

Authors:  Manjul Tripathi; Nishanth Sadashiva
Journal:  J Neurosci Rural Pract       Date:  2022-02-17

2.  Rodent Model of Brain Radionecrosis Using Clinical LINAC-Based Stereotactic Radiosurgery.

Authors:  Sean P Devan; Guozhen Luo; Xiaoyu Jiang; Jingping Xie; Daniel Dean; Levi S Johnson; Manuel Morales-Paliza; Hannah Harmsen; Junzhong Xu; Austin N Kirschner
Journal:  Adv Radiat Oncol       Date:  2022-07-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.